Beta Drugs Limited — Board Meeting, 25-05-2026: Outcome of Board Meeting
25-05-2026 · 12:10 pm
Beta Drugs' board approved converting Compulsory Convertible Debentures, issuing 6,65,314 new equity shares valued at approximately ₹0.67 Cr to Healthquad Trust II & Inti Capital VCC. This expands the company's equity base.
No comments yet. Be the first to comment!
